MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,240 Cr | ₹2,681 Cr | ₹2,190 Cr | ₹1,660 Cr | ₹1,228 Cr |
What is the latest Total Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,240 Cr |
| Mar2024 | ₹2,681 Cr |
| Mar2023 | ₹2,190 Cr |
| Mar2022 | ₹1,660 Cr |
| Mar2021 | ₹1,228 Cr |
How is Total Liabilities of MARKSANS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,240 Cr | 20.84 | |
| Mar2024 | ₹2,681 Cr | 22.40 | |
| Mar2023 | ₹2,190 Cr | 31.94 | |
| Mar2022 | ₹1,660 Cr | 35.19 | |
| Mar2021 | ₹1,228 Cr | - | |
Compare Total Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,815.4 Cr | -5% | -10.6% | -37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -5% |
-10.6% |
-37.1% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses